<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03439358</url>
  </required_header>
  <id_info>
    <org_study_id>H17-02408</org_study_id>
    <nct_id>NCT03439358</nct_id>
  </id_info>
  <brief_title>Magnesium for Shivering in Epidural Lidocaine Deliveries</brief_title>
  <acronym>Mag-SHIELD</acronym>
  <official_title>Intravenous Magnesium Sulfate for the Prevention of Intraoperative Shivering in Parturients Undergoing Cesarean Delivery Under Lidocaine Top-up Via a Pre-existing Epidural Catheter Inserted for Labor Analgesia - A Randomized Double-blind, Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Magnesium has been shown to decrease the shivering experienced from neuraxial anesthesia.
      This study aims to investigate whether magnesium decreases the shivering experienced in
      parturients undergoing labor epidural anesthesia for Cesarean delivery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women who have epidurals in place and go on to require a Cesarean delivery typically have
      their epidurals 'topped-up' with a fast onset local anesthetic to ensure the lower body is
      fully numb for surgery. This is called an epidural 'top-up'. However, a side effect of
      epidural top-ups is shivering, which is uncomfortable for the mother and interferes with
      patient monitoring. Magnesium administration has been shown to decrease shivering in the
      non-pregnant population. Therefore, in this study the investigators aim to determine if
      magnesium given prior to an epidural top-up decreases the incidence and severity of shivering
      in the pregnant population.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 2018</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of intraoperative shivering</measure>
    <time_frame>Through completion of cesarean surgical procedure (maximum 2 hours)</time_frame>
    <description>Incidence measured as shivering present or absent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of intraoperative shivering</measure>
    <time_frame>Through completion of cesarean surgical procedure (maximum 2 hours)</time_frame>
    <description>Severity measured subjectively by anesthesiologist and patient</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypothermia</measure>
    <time_frame>Through study completion (maximum 2.5 hours)</time_frame>
    <description>Number of patients whose tympanic membrane temperature decreases below 36 degrees Celsius.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypotension</measure>
    <time_frame>Through study completion (maximum 2.5 hours)</time_frame>
    <description>Number of patients who experience a greater than or equal to 20% reduction in systolic blood pressure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total vasopressor(s) dose</measure>
    <time_frame>Through study completion (maximum 2.5 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total utertonic(s) dose</measure>
    <time_frame>Through completion of cesarean surgical procedure (maximum 2 hours)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Magnesium sulfate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Magnesium sulfate (MgSO4) infusion will be commenced prior to epidural top-up.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline infusion will be commenced prior to epidural top-up.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <description>Bolus infusion: 100mL normal saline with 4g MgSO4 over 30 minutes Maintenance infusion: 25mL normal saline per hour with 1g MgSO4</description>
    <arm_group_label>Magnesium sulfate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <description>Bolus infusion: 100mL normal saline over 30 minutes Maintenance infusion: 25mL normal saline per hour</description>
    <arm_group_label>Normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Gestational age of ≥37 weeks

          2. Women who are ≥ 19 years old

          3. Women undergoing Cesarean delivery under lidocaine top-up via a preexisting epidural
             catheter inserted for labor analgesia

          4. American Society of Anesthesiologist (ASA) Physical Status class 1 or 2

        Exclusion Criteria:

          1. Emergency Cesarean delivery with limited time for informed consent

          2. Women who have received MgSO4 prior to study enrollment

          3. Indication for alternative mode of anesthesia for Cesarean delivery (e.g., general
             anesthesia)

          4. Medical conditions or medications that could lead to tremor or shivering. (e.g.,
             movement disorder, untreated thyroid disease) or mask tremor or shivering (e.g.,
             beta-blocker, benzodiazepine, anticonvulsants)

          5. Active shivering at time of recruitment

          6. Inability to read and understand English for the purpose of informed consent

          7. Contraindications to receiving MgSO4 (hypersensitivity reactions, respiratory rate
             &lt;16breaths/min, absent reflexes, urine output &lt;100 mL during the previous 4 hours,
             renal failure, or hypocalcemia)

          8. History of previous postpartum hemorrhage
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anton Chau, MD MMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anna West, BA MBBS</last_name>
    <role>Study Chair</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vit Gunka, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jonathan Collins, BA BM BCh MA</last_name>
    <role>Study Chair</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Monica Brunner, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arianne Albert, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Provincial Health Services Authority</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James D Taylor, BSc</last_name>
    <role>Study Chair</role>
    <affiliation>Provincial Health Services Authority</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>James D Taylor, BSc</last_name>
    <phone>604-875-2424</phone>
    <phone_ext>6076</phone_ext>
    <email>james.taylor1@phsa.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anna West, BA MBBS</last_name>
    <phone>604-875-2424</phone>
    <phone_ext>6076</phone_ext>
    <email>anna.west@cw.bc.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>BC Women's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3N1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James D Taylor, BSc</last_name>
      <phone>604-875-2424</phone>
      <phone_ext>6076</phone_ext>
      <email>james.taylor1@phsa.ca</email>
    </contact>
    <contact_backup>
      <last_name>Anna West, BA MBBS</last_name>
      <phone>604-875-2424</phone>
      <phone_ext>6076</phone_ext>
      <email>anna.west@cw.bc.ca</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2018</study_first_submitted>
  <study_first_submitted_qc>February 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 20, 2018</study_first_posted>
  <last_update_submitted>May 21, 2018</last_update_submitted>
  <last_update_submitted_qc>May 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Anton Chau</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Epidural top-up</keyword>
  <keyword>Shivering</keyword>
  <keyword>Magnesium</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

